These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 19839049)
1. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Tryndyak VP; Beland FA; Pogribny IP Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049 [TBL] [Abstract][Full Text] [Related]
2. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer. Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512 [TBL] [Abstract][Full Text] [Related]
3. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X; Ding X; Li X; Gao S; Yang Q Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Hurteau GJ; Carlson JA; Spivack SD; Brock GJ Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704 [TBL] [Abstract][Full Text] [Related]
5. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
6. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. Asakura T; Yamaguchi N; Ohkawa K; Yoshida K Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119 [TBL] [Abstract][Full Text] [Related]
9. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528 [TBL] [Abstract][Full Text] [Related]
10. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022 [TBL] [Abstract][Full Text] [Related]
11. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084 [TBL] [Abstract][Full Text] [Related]
12. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666 [TBL] [Abstract][Full Text] [Related]
13. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells. Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803 [TBL] [Abstract][Full Text] [Related]
14. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Park SM; Gaur AB; Lengyel E; Peter ME Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893 [TBL] [Abstract][Full Text] [Related]
15. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
16. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653 [TBL] [Abstract][Full Text] [Related]
17. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells. Fukagawa A; Ishii H; Miyazawa K; Saitoh M Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069 [TBL] [Abstract][Full Text] [Related]
18. Epithelial to mesenchymal transition is associated with rapamycin resistance. Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619 [TBL] [Abstract][Full Text] [Related]
19. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes. Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945 [TBL] [Abstract][Full Text] [Related]
20. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma. Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]